Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Differential response to cognitive therapy in parolees with primary and secondary substance use disorders.

Nishith P, Mueser KT, Srsic CS, Beck AT.

J Nerv Ment Dis. 1997 Dec;185(12):763-6. No abstract available.

PMID:
9442189
2.

The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.

Tsuang D, Cowley D, Ries R, Dunner DL, Roy-Byrne PP.

J Clin Psychiatry. 1995 Dec;56(12):549-55.

PMID:
8530330
3.

Quality of life and family history in pathological gambling.

Black DW, Moyer T, Schlosser S.

J Nerv Ment Dis. 2003 Feb;191(2):124-6. No abstract available.

PMID:
12586967
4.

Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation.

Ross HE, Swinson R, Larkin EJ, Doumani S.

J Nerv Ment Dis. 1994 Oct;182(10):556-63.

PMID:
7931203
5.

Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.

Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET.

J Clin Psychiatry. 2002 Feb;63(2):126-34.

PMID:
11874213
6.

Comorbidity among anxiety disorders: implications for treatment and DSM-IV.

Brown TA, Barlow DH.

J Consult Clin Psychol. 1992 Dec;60(6):835-44. Review.

PMID:
1460147
7.

Psychiatric disorders among drug dependent subjects: are they primary or secondary?

Compton WM 3rd, Cottler LB, Phelps DL, Ben Abdallah A, Spitznagel EL.

Am J Addict. 2000 Spring;9(2):126-34.

PMID:
10934574
8.

Screening for psychopathology in the clinical practice.

Eland-Goossensen A, van de Goor I, Garretsen H, Schudel J.

J Subst Abuse Treat. 1997 Nov-Dec;14(6):585-91.

PMID:
9437632
9.
10.

Comorbidity and the treatment of principal anxiety disorders in a naturalistic sample.

Davis L, Barlow DH, Smith L.

Behav Ther. 2010 Sep;41(3):296-305. doi: 10.1016/j.beth.2009.09.002. Epub 2010 Feb 1.

PMID:
20569779
11.

Comorbidity.

Angold A, Costello EJ, Erkanli A.

J Child Psychol Psychiatry. 1999 Jan;40(1):57-87. Review.

PMID:
10102726
12.

Psychiatric symptomatology in crack cocaine abusers.

Sterling RC, Gottheil E, Weinstein SP, Shannon DM.

J Nerv Ment Dis. 1994 Oct;182(10):564-9.

PMID:
7931204
13.

Co-morbidity of lifetime psychiatric disorder among male alcoholic patients.

Penick EC, Powell BJ, Nickel EJ, Bingham SF, Riesenmy KR, Read MR, Campbell J.

Alcohol Clin Exp Res. 1994 Dec;18(6):1289-93.

PMID:
7695019
14.

Hospital-based adolescent substance abuse treatment: comorbidity, outcomes, and gender.

Rivers SM, Greenbaum RL, Goldberg E.

J Nerv Ment Dis. 2001 Apr;189(4):229-37.

PMID:
11339318
15.

The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.

McEvoy PM, Shand F.

J Anxiety Disord. 2008 Aug;22(6):1087-98. doi: 10.1016/j.janxdis.2007.11.007. Epub 2007 Nov 21.

PMID:
18164585
16.

Prevalence and clinical features of body dysmorphic disorder in atypical major depression.

Phillips KA, Nierenberg AA, Brendel G, Fava M.

J Nerv Ment Dis. 1996 Feb;184(2):125-9. No abstract available.

PMID:
8596110
17.

Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K.

Arch Gen Psychiatry. 2004 Aug;61(8):807-16.

PMID:
15289279
19.

Psychiatric and medical comorbidities of bipolar disorder.

Krishnan KR.

Psychosom Med. 2005 Jan-Feb;67(1):1-8. Review.

PMID:
15673617
20.

Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers.

Cecero JJ, Ball SA, Tennen H, Kranzler HR, Rounsaville BJ.

J Nerv Ment Dis. 1999 Aug;187(8):478-86.

PMID:
10463065
Items per page

Supplemental Content

Write to the Help Desk